Company Search:
Advanced Search
Sponsored Links
Livzon Pharmaceutical Group Incorporated Company Snapshot
Livzon Pharmaceutical Group Incorporated operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Livzon Pharmaceutical Group Incorporated with three other companies in this sector in China: North China Pharmaceutical, Limited (2016 sales of 8.08 billion Chinese Renmimbi [US$1.28 billion] of which 43% was Chemical Preparation Medicine), Huapont-Nutrichem Co Ltd (7.09 billion Chinese Renmimbi [US$1.12 billion] of which 68% was Agricultural Business), and Chongqing Taiji Industry (Group) (7.78 billion Chinese Renmimbi [US$1.23 billion] of which 52% was Trading).

Sales Analysis. During the year ended December of 2016, sales at Livzon Pharmaceutical Group Incorporated were 7.65 billion Chinese Renmimbi (US$1.21 billion). This is an increase of 15.5% versus 2015, when the company's sales were 6.62 billion Chinese Renmimbi. This was the fifth consecutive year of sales increases at Livzon Pharmaceutical Group Incorporated (and since 2011, sales have increased a total of 142%). Sales of Western Medicine saw an increase of 23.4% in 2016, from 2.58 billion Chinese Renmimbi to 3.19 billion Chinese Renmimbi. Not all segments of Livzon Pharmaceutical Group Incorporated experienced an increase in sales in 2016: sales of Other fell 75.0% to 1.43 million Chinese Renmimbi. (However, this segment's sales were only a very small portion of the company's overall sales). Livzon Pharmaceutical Group Incorporated also experienced decreases in sales in Other Operatings (down 66.2% to 35.11 million Chinese Renmimbi) .
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Livzon Pharmaceutical Group Incorporated
  Stock Performance Chart for Livzon Pharmaceutical Group Incorporated
  Stock Data: Recent Stock Performance:
  Current Price (3/16/2018): 73.56
(Figures in Chinese Renmimbi)
1 Week -1.8%   13 Weeks 7.1%  
4 Weeks 8.3%   52 Weeks 75.8%  
Livzon Pharmaceutical Group Incorporated Key Data:
  Ticker: 000513 Country: China
  Exchanges: SZN Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2016 Sales 7,648,988,329
(Year Ending Jan 2017).
Employees: 6,297
  Currency: Chinese Renmimbi Market Cap: 40,695,699,504
  Fiscal Yr Ends: December Shares Outstanding: 553,231,369
  Share Type: A Gu Closely Held Shares: 274,949,632
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.